Anesthesia Options and the Recurrence of Cancer: What We Know so Far?

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Cata JP, Bauer M, Sokari T, et al. Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer. J Clin Anesth. 2013;25(4):255–262. doi:10.1016/j.jclinane.2012.12.00723659826
   PubMed Web of Science ®Google Scholar
• Ramirez MF, Ai D, Bauer M, et al. Innate immune function after breast, lung, and colorectal cancer surgery. J Surg Res. 2015;194(1):185–193. doi:10.1016/j.jss.2014.10.03025475022
   PubMed Web of Science ®Google Scholar
• Cata JP, Gottumukkala V, Sessler DI. How regional anesthesia might reduce postoperative cancer recurrence. Eur J Pain Suppl. 2012;5(S2):345–355. doi:10.1016/j.eujps.2011.08.017
   Google Scholar
• Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15(4):205–218. doi:10.1038/nrclinonc.2017.19429283170
   PubMed Web of Science ®Google Scholar
• Wigmore TJ, Mohammed K, Jhanji S. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: a retrospective analysis. Anesthesiology. 2016;124(1):69–79. doi:10.1097/ALN.000000000000093626556730
   PubMed Web of Science ®Google Scholar
• Novy DM, Nelson DV, Koyyalagunta D, Cata JP, Gupta P, Gupta K. Pain, opioid therapy, and survival: a needed discussion. Pain. 2019.
   Google Scholar
• Wirz S, Schenk M, Kieselbach K. Schmerztherapeutische Aspekte bei Tumoroperationen. Anasthesiol Intensivmed Notfallmed Schmerzther. 2018;53(10):704–717. doi:10.1055/s-0043-10460030423596
   PubMed Web of Science ®Google Scholar
• Sessler DI, Pei L, Huang Y, et al. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet. 2019;394(10211):1807–1815. doi:10.1016/S0140-6736(19)32313-X31645288
   PubMed Web of Science ®Google Scholar
• Naxerova K, Jain RK. Using tumour phylogenetics to identify the roots of metastasis in humans. Nat Rev Clin Oncol. 2015;12(5):258–272. doi:10.1038/nrclinonc.2014.23825601447
   PubMed Web of Science ®Google Scholar
• Raskov H, Orhan A, Salanti A, Gogenur I. Premetastatic niches, exosomes and circulating tumor cells: early mechanisms of tumor dissemination and the relation to surgery. Int J Cancer. 2019.
   Web of Science ®Google Scholar
• Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670–691. doi:10.1016/j.cell.2016.11.03728187288
   PubMed Web of Science ®Google Scholar
• Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611–622. doi:10.1038/nrc379325118602
   PubMed Web of Science ®Google Scholar
• Massague J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529(7586):298–306. doi:10.1038/nature1703826791720
   PubMed Web of Science ®Google Scholar
• Krall JA, Reinhardt F, Mercury OA, et al. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy. Sci Transl Med. 2018;10(436):eaan3464. doi:10.1126/scitranslmed.aan346429643230
   PubMed Web of Science ®Google Scholar
• Tohme S, Yazdani HO, Al-Khafaji AB, et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 2016;76(6):1367–1380. doi:10.1158/0008-5472.CAN-15-159126759232
   PubMed Web of Science ®Google Scholar
• Eustache JH, Tohme S, Milette S, Rayes RF, Tsung A, Spicer JD. Casting A wide net on surgery: the central role of neutrophil extracellular traps. Ann Surg. 2019. doi:10.1097/SLA.0000000000003586
   Web of Science ®Google Scholar
• Sorski L, Melamed R, Matzner P, et al. Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through beta-adrenoceptors blockade and COX2 inhibition. Brain Behav Immun. 2016;58:91–98. doi:10.1016/j.bbi.2016.05.01727235931
   PubMed Web of Science ®Google Scholar
• de Andrade LF, Lu Y, Luoma A, et al. Discovery of specialized NK cell populations infiltrating human melanoma metastases. JCI Insight. 2019;4(23). doi:10.1172/jci.insight.133103.
   Web of Science ®Google Scholar
• Kim BJ, Caudle AS, Gottumukkala V, Aloia TA. The impact of postoperative complications on a timely return to intended oncologic therapy (RIOT). Int Anesthesiol Clin. 2016;54(4):e33–e46. doi:10.1097/AIA.000000000000011327623128
   PubMedGoogle Scholar
• Han WH, Oh YJ, Eom BW, Yoon HM, Kim Y-W, Ryu KW. Prognostic impact of infectious complications after curative gastric cancer surgery. Eur J Surg Oncol. 2020;46(7):1233–1238. doi:10.1016/j.ejso.2020.04.03232362466
   PubMed Web of Science ®Google Scholar
• Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth. 2013;110(5):690–701. doi:10.1093/bja/aet06823599512
   PubMed Web of Science ®Google Scholar
• Della Rocca G, Vetrugno L, Coccia C, et al. Preoperative evaluation of patients undergoing lung resection surgery: defining the role of the anesthesiologist on a multidisciplinary team. J Cardiothorac Vasc Anesth. 2016;30(2):530–538. doi:10.1053/j.jvca.2015.11.01827013123
   PubMed Web of Science ®Google Scholar
• Wall TP, Crowley PD, Sherwin A, Foley AG, Buggy DJ. Effects of lidocaine and src inhibition on metastasis in a murine model of breast cancer surgery. Cancers. 2019;11(10):1414. doi:10.3390/cancers11101414
   Web of Science ®Google Scholar
• Freeman J, Crowley PD, Foley AG, et al. Effect of perioperative lidocaine, propofol and steroids on pulmonary metastasis in a murine model of breast cancer surgery. Cancers. 2019;11(5):613. doi:10.3390/cancers11050613
   PubMed Web of Science ®Google Scholar
• Zhang Y, Peng X, Zheng Q. Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK. Biochem Biophys Res Commun. 2018;501(4):1074–1079. doi:10.1016/j.bbrc.2018.05.11029777701
   PubMed Web of Science ®Google Scholar
• Jiang Y, Gou H, Zhu J, Tian S, Yu L. Lidocaine inhibits the invasion and migration of TRPV6-expressing cancer cells by TRPV6 downregulation. Oncol Lett. 2016;12(2):1164–1170. doi:10.3892/ol.2016.470927446413
   PubMed Web of Science ®Google Scholar
• Baptista-Hon DT, Robertson FM, Robertson GB, et al. Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and Na V 1.5 channel function. Br J Anaesth. 2014;113:i39–i48. doi:10.1093/bja/aeu10424852501
   PubMed Web of Science ®Google Scholar
• Brisson L, Driffort V, Benoist L, et al. NaV1.5 Na(+) channels allosterically regulate the NHE-1 exchanger and promote the activity of breast cancer cell invadopodia. J Cell Sci. 2013;126(Pt 21):4835–4842. doi:10.1242/jcs.12390123902689
   PubMed Web of Science ®Google Scholar
• Brackenbury WJ. Voltage-gated sodium channels and metastatic disease. Channels. 2014;6(5):352–361. doi:10.4161/chan.21910
   Web of Science ®Google Scholar
• Gao J, Hu H, Wang X. Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling. Cancer Chemother Pharmacol. 2019;83(6):1007–1015. doi:10.1007/s00280-019-03815-430887179
   PubMed Web of Science ®Google Scholar
• Yang J, Li G, Bao K, Liu W, Zhang Y, Ting W. Ropivacaine inhibits tumor angiogenesis via sodium-channel-independent mitochondrial dysfunction and oxidative stress. J Bioenerg Biomembr. 2019;51(3):231–238. doi:10.1007/s10863-019-09793-930847691
   PubMed Web of Science ®Google Scholar
• Johnson MZ, Crowley PD, Foley AG, et al. Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model. Br J Anaesth. 2018;121(1):76–85. doi:10.1016/j.bja.2017.12.04329935598
   PubMed Web of Science ®Google Scholar
• Piegeler T, Schlapfer M, Dull RO, et al. Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFalpha-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase. Br J Anaesth. 2015;115(5):784–791. doi:10.1093/bja/aev34126475807
   PubMed Web of Science ®Google Scholar
• Piegeler T, Votta-Velis E, Liu G, et al. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology. 2012;117(3):548–559. doi:10.1097/ALN.0b013e318266197722846676
   PubMed Web of Science ®Google Scholar
• Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009;109(5):1464–1469. doi:10.1213/ANE.0b013e3181bab1bd19843784
   PubMed Web of Science ®Google Scholar
• Chen LJ, Ding YB, Ma PL, et al. The protective effect of lidocaine on lipopolysaccharide-induced acute lung injury in rats through NF-kappaB and p38 MAPK signaling pathway and excessive inflammatory responses. Eur Rev Med Pharmacol Sci. 2018;22(7):2099–2108. doi:10.26355/eurrev_201804_1474329687869
   PubMed Web of Science ®Google Scholar
• Shin E-C, Jeon Y-T, Na H, Ryu H, Chung Y. Modulation of dendritic cell activation and subsequent Th1 cell polarization by lidocaine. PLoS One. 2015;10(10): e0139845.26445366
   PubMed Web of Science ®Google Scholar
• Hmadcha A, Bedoya FJ, Sobrino F, Pintado E. Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med. 1999;190(11):1595–1604. doi:10.1084/jem.190.11.159510587350
   PubMed Web of Science ®Google Scholar
• Qian X, Huang C, Cho CH, Hui WM, Rashid A, Chan AO. E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines. Cancer Lett. 2008;263(1):107–113. doi:10.1016/j.canlet.2007.12.02318249489
   PubMed Web of Science ®Google Scholar
• Lirk P, Hollmann MW, Fleischer M, Weber NC, Fiegl H. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. Br J Anaesth. 2014;113(Suppl 1):i32–38. doi:10.1093/bja/aeu20124946779
   PubMed Web of Science ®Google Scholar
• Lirk P, Berger R, Hollmann MW, Fiegl H. Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. Br J Anaesth. 2012;109(2):200–207. doi:10.1093/bja/aes12822542536
   PubMed Web of Science ®Google Scholar
• Li K, Yang J, Han X. Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARbeta2 and RASSF1A demethylation. Int J Mol Sci. 2014;15(12):23519–23536. doi:10.3390/ijms15122351925526566
   PubMed Web of Science ®Google Scholar
• Zhu J, Han S. Lidocaine inhibits cervical cancer cell proliferation and induces cell apoptosis by modulating the lncRNA-MEG3/miR-421/BTG1 pathway. Am J Transl Res. 2019;11(9):5404–5416.31632519
   PubMed Web of Science ®Google Scholar
• Sun H, Sun Y. Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis. Artif Cells Nanomed Biotechnol. 2019;47(1):2866–2874. doi:10.1080/21691401.2019.163680731299862
   PubMed Web of Science ®Google Scholar
• Xia W, Wang L, Yu D, Mu X, Zhou X. Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR520a3p/EGFR axis. Mol Med Rep. 2019;20(2):1333–1342. doi:10.3892/mmr.2019.1036331173241
   PubMed Web of Science ®Google Scholar
• Sui H, Lou A, Li Z, Yang J. Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145. BMC Cancer. 2019;19(1):233. doi:10.1186/s12885-019-5431-930876463
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang Z, Xu H, Ma C. Lidocaine alleviates cytotoxicity-resistance in lung cancer A549/DDP cells via down-regulation of miR-21. Mol Cell Biochem. 2019;456(1–2):63–72. doi:10.1007/s11010-018-3490-x30644017
   PubMed Web of Science ®Google Scholar
• Wang Y, Xie J, Liu W, Zhang R, Huang S, Xing Y. Lidocaine sensitizes the cytotoxicity of 5-fluorouacil in melanoma cells via upregulation of microRNA-493. Pharmazie. 2017;72(11):663–669. doi:10.1691/ph.2017.761629442040
   PubMed Web of Science ®Google Scholar
• House CD, Vaske CJ, Schwartz AM, et al. Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res. 2010;70(17):6957–6967. doi:10.1158/0008-5472.CAN-10-116920651255
   PubMed Web of Science ®Google Scholar
• Gong X, Dan J, Li F, Wang L. Suppression of mitochondrial respiration with local anesthetic ropivacaine targets breast cancer cells. J Thorac Dis. 2018;10(5):2804–2812. doi:10.21037/jtd.2018.05.2129997943
   PubMed Web of Science ®Google Scholar
• Cata JP, Ramirez MF, Velasquez JF, et al. Lidocaine stimulates the function of natural killer cells in different experimental settings. Anticancer Res. 2017;37(9):4727–4732. doi:10.21873/anticanres.1187928870891
   PubMed Web of Science ®Google Scholar
• Ramirez MF, Tran P, Cata JP. The effect of clinically therapeutic plasma concentrations of lidocaine on natural killer cell cytotoxicity. Reg Anesth Pain Med. 2015;40(1):43–48. doi:10.1097/AAP.000000000000019125469757
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Itano Y, Mizobuchi S, et al. The effects of epidural block on the distribution of lymphocyte subsets and natural-killer cell activity in patients with and without pain. Anesth Analg. 2001;92(2):463–469. doi:10.1213/00000539-200102000-0003511159252
   PubMed Web of Science ®Google Scholar
• Wang H-L, Yan H-D, Liu -Y-Y, et al. Intraoperative intravenous lidocaine exerts a protective effect on cell-mediated immunity in patients undergoing radical hysterectomy. Mol Med Rep. 2015;12(5):7039–7044. doi:10.3892/mmr.2015.423526299324
   PubMed Web of Science ®Google Scholar
• Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 2000;10(2):165–169. doi:10.1097/00008390-200004000-0000910803717
   PubMed Web of Science ®Google Scholar
• Kofler L, Breuninger H, Häfner H-M, et al. Lymph node dissection for melanoma using tumescence local anaesthesia: an observational study. Eur J Dermatol. 2018;28(2):177–185. doi:10.1684/ejd.2018.325029620000
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang L, Zhu X, et al. Association between intraoperative intravenous lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective study. Br J Anaesth. 2020. doi:10.1016/j.bja.2020.03.034
   Web of Science ®Google Scholar
• Pérez-González O, Cuéllar-Guzmán LF, Soliz J, Cata JP. Impact of regional anesthesia on recurrence, metastasis, and immune response in breast cancer surgery: a systematic review of the literature. Reg Anesth Pain Med. 2017;42(6):751–756. doi:10.1097/AAP.000000000000066228953508
   PubMed Web of Science ®Google Scholar
• Pei L, Tan G, Wang L, et al. Comparison of combined general-epidural anesthesia with general anesthesia effects on survival and cancer recurrence: a meta-analysis of retrospective and prospective studies. PLoS One. 2014;9(12):e114667–e114667. doi:10.1371/journal.pone.011466725548913
   PubMed Web of Science ®Google Scholar
• Cummings KC 3rd, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology. 2012;116(4):797–806. doi:10.1097/ALN.0b013e31824674f622273991
   PubMed Web of Science ®Google Scholar
• Gottschalk A, Ford JG, Regelin CC, et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology. 2010;113(1):27–34. doi:10.1097/ALN.0b013e3181de6d0d20508494
   PubMed Web of Science ®Google Scholar
• Gupta A, Bjornsson A, Fredriksson M, Hallbook O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth. 2011;107(2):164–170. doi:10.1093/bja/aer10021586443
   PubMed Web of Science ®Google Scholar
• Day A, Smith R, Jourdan I, Fawcett W, Scott M, Rockall T. Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer. Br J Anaesth. 2012;109(2):185–190. doi:10.1093/bja/aes10622525284
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim NK, Baik SH, et al. Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer: a randomized study. Medicine (Baltimore). 2016;95(19):e3602. doi:10.1097/MD.000000000000360227175664
   PubMed Web of Science ®Google Scholar
• Zimmitti G, Soliz J, Aloia TA, et al. Positive impact of epidural analgesia on oncologic outcomes in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. 2016;23(3):1003–1011. doi:10.1245/s10434-015-4933-126511261
   PubMed Web of Science ®Google Scholar
• Gao H, Meng X-Y, Wang H-Q, et al. Association between anaesthetic technique and oncological outcomes after colorectal carcinoma liver metastasis resection. Int J Med Sci. 2019;16(2):337–342. doi:10.7150/ijms.2801630745816
   PubMed Web of Science ®Google Scholar
• Garland M, Addis D, Russell G, et al. The effect of regional anesthesia on oncologic outcomes after resection of colorectal hepatic metastases. Am Surg. 2018;84(1):29–32.29642984
   PubMed Web of Science ®Google Scholar
• Pérez-González O, Cuéllar-Guzmán LF, Navarrete-Pacheco M, Ortiz-Martínez JJ, Williams WH, Cata JP. Impact of regional anesthesia on gastroesophageal cancer surgery outcomes: a systematic review of the literature. Anesth Analg. 2018;127(3):753–758. doi:10.1213/ANE.000000000000360229958224
   PubMed Web of Science ®Google Scholar
• Zheng L, Hagan KB, Villarreal J, Keerty V, Chen J, Cata JP. Scalp block for glioblastoma surgery is associated with lower inflammatory scores and improved survival. Minerva Anestesiol. 2017;83(11):1137–1145. doi:10.23736/S0375-9393.17.11881-X28497933
   PubMed Web of Science ®Google Scholar
• Cata JP, Bhavsar S, Hagan KB, et al. Scalp blocks for brain tumor craniotomies: a retrospective survival analysis of a propensity match cohort of patients. J Clin Neurosci. 2018;51:46–51. doi:10.1016/j.jocn.2018.02.02229514747
   PubMed Web of Science ®Google Scholar
• Lai R, Peng Z, Chen D, et al. The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth Analg. 2012;114(2):290–296. doi:10.1213/ANE.0b013e318239c2e322104077
   PubMed Web of Science ®Google Scholar
• Merquiol F, Montelimard A-S, Nourissat A, Molliex S, Zufferey PJ. Cervical epidural anesthesia is associated with increased cancer-free survival in laryngeal and hypopharyngeal cancer surgery: a retrospective propensity-matched analysis. Reg Anesth Pain Med. 2013;38(5):398–402. doi:10.1097/AAP.0b013e31829cc3fb23881179
   PubMedGoogle Scholar
• Cata JP, Gottumukkala V, Thakar D, Keerty D, Gebhardt R, Liu DD. Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer. J Clin Anesth. 2014;26(1):3–17. doi:10.1016/j.jclinane.2013.06.00724095887
   PubMed Web of Science ®Google Scholar
• Lee EK, Ahn HJ, Zo JI, Kim K, Jung DM, Park JH. Paravertebral block does not reduce cancer recurrence, but is related to higher overall survival in lung cancer surgery: a retrospective cohort study. Anesth Analg. 2017;125(4):1322–1328. doi:10.1213/ANE.000000000000234228857802
   PubMed Web of Science ®Google Scholar
• Huang -W-W, Zhu W-Z, Mu D-L, et al. Perioperative management may improve long-term survival in patients after lung cancer surgery: a retrospective cohort study. Anesth Analg. 2018;126(5):1666–1674. doi:10.1213/ANE.000000000000288629517574
   PubMed Web of Science ®Google Scholar
• Wu H-L, Tai Y-H, Chan M-Y, Tsou M-Y, Chen -H-H, Chang K-Y. Effects of epidural analgesia on cancer recurrence and long-term mortality in patients after non-small-cell lung cancer resection: a propensity score-matched study. BMJ Open. 2019;9(5):e027618. doi:10.1136/bmjopen-2018-027618
   PubMed Web of Science ®Google Scholar
• Gottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth. 2012;109(2):253–259. doi:10.1093/bja/aes17622705968
   PubMed Web of Science ®Google Scholar
• de Oliveira GS Jr., Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med. 2011;36(3):271–277. doi:10.1097/AAP.0b013e318217aada21519312
   PubMed Web of Science ®Google Scholar
• Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth. 2011;106(6):814–822. doi:10.1093/bja/aer05521436156
   PubMed Web of Science ®Google Scholar
• Capmas P, Billard V, Gouy S, et al. Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer. Anticancer Res. 2012;32(4):1537–1542.22493398
   PubMed Web of Science ®Google Scholar
• Lacassie HJ, Cartagena J, Brañes J, Assel M, Echevarría GC. The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population. Anesth Analg. 2013;117(3):653–660. doi:10.1213/ANE.0b013e3182a0704623868889
   PubMed Web of Science ®Google Scholar
• Tseng JH, Cowan RA, Afonso AM, et al. Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2018;151(2):287–293. doi:10.1016/j.ygyno.2018.08.02430185381
   PubMed Web of Science ®Google Scholar
• Zhong S, Zhong X, Zhong X, Liu Y. Comparison between the effect of epidural anesthesia combined with epidural analgesia and general anesthesia combined with intravenous analgesia on prognosis of ovarian cancer patients. Oncol Lett. 2019;17(6):5662–5668. doi:10.3892/ol.2019.1021631186789
   PubMed Web of Science ®Google Scholar
• Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol. 2015;22(4):1341–1348.25287437
   PubMed Web of Science ®Google Scholar
• Grandhi RK, Lee S, Abd-Elsayed A. The Relationship Between Regional Anesthesia and Cancer: a Metaanalysis. Ochsner J. 2017;17(4):345–361.29230120
   PubMed Web of Science ®Google Scholar
• Lee BM, Singh Ghotra V, Karam JA, Hernandez M, Pratt G, Cata JP. Regional anesthesia/analgesia and the risk of cancer recurrence and mortality after prostatectomy: a meta-analysis. Pain Manag. 2015;5:387–395.26250850
   PubMedGoogle Scholar
• Chipollini J, Alford B, Boulware DC, et al. Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center. BMC Anesthesiol. 2018;18(1):157. doi:10.1186/s12871-018-0622-530390636
   PubMed Web of Science ®Google Scholar
• Cakmakkaya OS, Kolodzie K, Apfel CC, Pace NL. Anaesthetic techniques for risk of malignant tumour recurrence. Cochrane Database Syst Rev. 2014;11:CD008877.
   Google Scholar
• Ma D, Pei L, Tan G, et al. Comparison of combined general-epidural anesthesia with general anesthesia effects on survival and cancer recurrence: a meta-analysis of retrospective and prospective studies. PLoS One. 2014;9(12): e114667.25548913
   PubMed Web of Science ®Google Scholar
• Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth. 2009;103(5):685–690. doi:10.1093/bja/aep26119776028
   PubMed Web of Science ®Google Scholar
• Deegan CA, Murray D, Doran P, et al. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med. 2010;35(6):490–495. doi:10.1097/AAP.0b013e3181ef4d0520975461
   PubMed Web of Science ®Google Scholar
• O’Riain SC, Buggy DJ, Kerin MJ, Watson RW, Moriarty DC. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg. 2005;100(1):244–249. doi:10.1213/01.ANE.0000143336.37946.7D15616085
   PubMed Web of Science ®Google Scholar
• Velasquez JF, Ramirez MF, Ai DI, Lewis V, Cata JP. Impaired immune function in patients undergoing surgery for bone cancer. Anticancer Res. 2015;35(10):5461–5466.26408709
   PubMed Web of Science ®Google Scholar
• Buckley A, McQuaid S, Johnson P, Buggy DJ. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study. Br J Anaesth. 2014;113(Suppl 1):i56–62. doi:10.1093/bja/aeu20025009196
   PubMed Web of Science ®Google Scholar
• Desmond F, McCormack J, Mulligan N, Stokes M, Buggy DJ. Effect of anaesthetic technique on immune cell infiltration in breast cancer: a follow-up pilot analysis of a prospective, randomised, investigator-masked study. Anticancer Res. 2015;35(3):1311–1319.25750280
   PubMed Web of Science ®Google Scholar
• Zhang W, Shao X. Isoflurane promotes non-small cell lung cancer malignancy by activating the Akt-mammalian target of rapamycin (mTOR) signaling pathway. Med Sci Monit. 2016;22:4644–4650. doi:10.12659/MSM.89843427897153
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Zhao H, Jaffer T, et al. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget. 2016;7(18):26042–26056. doi:10.18632/oncotarget.830427028996
   PubMedGoogle Scholar
• Luo X, Zhao H, Hennah L, et al. Impact of isoflurane on malignant capability of ovarian cancer in vitro ‡. Br J Anaesth. 2015;114(5):831–839. doi:10.1093/bja/aeu40825501719
   PubMed Web of Science ®Google Scholar
• Ciechanowicz S, Zhao H, Chen Q, et al. Differential effects of sevoflurane on the metastatic potential and chemosensitivity of non-small-cell lung adenocarcinoma and renal cell carcinoma in vitro. Br J Anaesth. 2018;120(2):368–375. doi:10.1016/j.bja.2017.11.06629406185
   PubMed Web of Science ®Google Scholar
• Moudgil GC, Singal DP. Halothane and isoflurane enhance melanoma tumour metastasis in mice. Can J Anaesth. 1997;44(1):90–94. doi:10.1007/BF030143318988831
   PubMed Web of Science ®Google Scholar
• Liang H, Yang CX, Zhang B, Zhao ZL, Zhong JY, Wen XJ. Sevoflurane attenuates platelets activation of patients undergoing lung cancer surgery and suppresses platelets-induced invasion of lung cancer cells. J Clin Anesth. 2016;35:304–312. doi:10.1016/j.jclinane.2016.08.00827871548
   PubMed Web of Science ®Google Scholar
• Xu YJ, Li SY, Cheng Q, et al. Effects of anaesthesia on proliferation, invasion and apoptosis of LoVo colon cancer cells in vitro. Anaesthesia. 2016;71(2):147–154. doi:10.1111/anae.1333126669824
   PubMed Web of Science ®Google Scholar
• Jaura AI, Flood G, Gallagher HC, Buggy DJ. Differential effects of serum from patients administered distinct anaesthetic techniques on apoptosis in breast cancer cells in vitro: a pilot study. Br J Anaesth. 2014;113(Suppl 1):i63–67. doi:10.1093/bja/aet58125009197
   PubMed Web of Science ®Google Scholar
• Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97(5):1331–1339. doi:10.1213/01.ANE.0000082995.44040.0714570648
   PubMed Web of Science ®Google Scholar
• Tazawa K, Koutsogiannaki S, Chamberlain M, Yuki K. The effect of different anesthetics on tumor cytotoxicity by natural killer cells. Toxicol Lett. 2017;266:23–31. doi:10.1016/j.toxlet.2016.12.00727940100
   PubMed Web of Science ®Google Scholar
• Meier A, Gross ETE, Schilling JM, et al. Isoflurane impacts murine melanoma growth in a sex-specific, immune-dependent manner. Anesth Analg. 2018;126(6):1910–1913. doi:10.1213/ANE.000000000000290229570154
   PubMed Web of Science ®Google Scholar
• Gao K, Su Z, Liu H, Liu Y. Anti-proliferation and anti-metastatic effects of sevoflurane on human osteosarcoma U2OS and Saos-2 cells. Exp Mol Pathol. 2019;108:121–130. doi:10.1016/j.yexmp.2019.04.00530974101
   PubMed Web of Science ®Google Scholar
• Gao C, Shen J, Meng Z-X, He X-F. Sevoflurane inhibits glioma cells proliferation and metastasis through miRNA-124-3p/ROCK1 axis. Pathol Oncol Res. 2019.
   Web of Science ®Google Scholar
• Fan L, Wu Y, Wang J, He J, Han X. Sevoflurane inhibits the migration and invasion of colorectal cancer cells through regulating ERK/MMP-9 pathway by up-regulating miR-203. Eur J Pharmacol. 2019;850:43–52. doi:10.1016/j.ejphar.2019.01.02530685432
   PubMed Web of Science ®Google Scholar
• Liang H, Yang CX, Zhang B, et al. Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1alpha. J Anesth. 2015;29(6):821–830. doi:10.1007/s00540-015-2035-726002230
   PubMed Web of Science ®Google Scholar
• Gallyas F, Sumi C, Matsuo Y, et al. Cancerous phenotypes associated with hypoxia-inducible factors are not influenced by the volatile anesthetic isoflurane in renal cell carcinoma. PLoS One. 2019;14(4): e0215072.30986231
   PubMed Web of Science ®Google Scholar
• Zhang YF, Li CS, Zhou Y, Lu XH. Effects of propofol on colon cancer metastasis through STAT3/HOTAIR axis by activating WIF-1 and suppressing Wnt pathway. Cancer Med. 2020 ;9(5):1842–1854.31953926
   PubMed Web of Science ®Google Scholar
• Qi J, Wu Q, Zhu X, et al. Propofol attenuates the adhesion of tumor and endothelial cells through inhibiting glycolysis in human umbilical vein endothelial cells. Acta Biochim Biophys Sin (Shanghai). 2019. doi:10.1093/abbs/gmz105
   Web of Science ®Google Scholar
• Guo XG, Wang S, Xu YB, Zhuang J. Propofol suppresses invasion, angiogenesis and survival of EC-1 cells in vitro by regulation of S100A4 expression. Eur Rev Med Pharmacol Sci. 2015;19(24):4858–4865.26744878
   PubMed Web of Science ®Google Scholar
• Xu YB, Du QH, Zhang MY, Yun P, He CY. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci. 2013;17(18):2486–2494.24089228
   PubMed Web of Science ®Google Scholar
• Sen Y, Xiyang H, Yu H. Effect of thoracic paraspinal block-propofol intravenous general anesthesia on VEGF and TGF-β in patients receiving radical resection of lung cancer. Medicine. 2019;98(47):e18088. doi:10.1097/MD.000000000001808831764844
   PubMed Web of Science ®Google Scholar
• Ferrell JK, Cattano D, Brown RE, Patel CB, Karni RJ. The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: a pilot study. Transl Res. 2015;166(6):674–682. doi:10.1016/j.trsl.2015.09.00126423449
   PubMed Web of Science ®Google Scholar
• Liu D, Sun X, Du Y, Kong M. Propofol promotes activity and tumor-killing ability of natural killer cells in peripheral blood of patients with colon cancer. Med Sci Monit. 2018;24:6119–6128. doi:10.12659/MSM.91121830174326
   PubMed Web of Science ®Google Scholar
• Zhou M, Dai J, Zhou Y, et al. Propofol improves the function of natural killer cells from the peripheral blood of patients with esophageal squamous cell carcinoma. Exp Ther Med. 2018;16(1):83–92.29977357
   PubMed Web of Science ®Google Scholar
• Inada T, Kubo K, Shingu K. Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E(2) production using intravenous anesthetic propofol. Int Immunopharmacol. 2010;10(10):1200–1208. doi:10.1016/j.intimp.2010.06.02720633531
   PubMed Web of Science ®Google Scholar
• Zhang T, Fan Y, Liu K, Wang Y. Effects of different general anaesthetic techniques on immune responses in patients undergoing surgery for tongue cancer. Anaesth Intensive Care. 2019;42(2):220–227. doi:10.1177/0310057X1404200209
   Web of Science ®Google Scholar
• Liu S, Gu X, Zhu L, et al. Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. Medicine. 2016;95(49):e5479. doi:10.1097/MD.000000000000547927930529
   PubMed Web of Science ®Google Scholar
• Oh C-S, Lee J, Yoon T-G, et al. Effect of equipotent doses of propofol versus sevoflurane anesthesia on regulatory T cells after breast cancer surgery. Anesthesiology. 2018;129(5):921–931. doi:10.1097/ALN.000000000000238230074934
   PubMed Web of Science ®Google Scholar
• Yan T, Zhang GH, Wang BN, Sun L, Zheng H. Effects of propofol/remifentanil-based total intravenous anesthesia versus sevoflurane-based inhalational anesthesia on the release of VEGF-C and TGF-beta and prognosis after breast cancer surgery: a prospective, randomized and controlled study. BMC Anesthesiol. 2018;18(1):131. doi:10.1186/s12871-018-0588-330243294
   PubMed Web of Science ®Google Scholar
• Soliz JM, Ifeanyi IC, Katz MH, et al. Comparing postoperative complications and inflammatory markers using total intravenous anesthesia versus volatile gas anesthesia for pancreatic cancer surgery. Anesthesiol Pain Med. 2017;7(4):e13879. doi:10.5812/aapm.13879
   Google Scholar
• Owusu-Agyemang P, Cata JP, Fournier KF, et al. Evaluating the impact of total intravenous anesthesia on the clinical outcomes and perioperative NLR and PLR profiles of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23(8):2419–2429. doi:10.1245/s10434-016-5176-526975738
   PubMed Web of Science ®Google Scholar
• Cata JP, Nguyen LT, Ifeanyi-Pillette IC, et al. An assessment of the survival impact of multimodal anesthesia/analgesia technique in adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched analysis. Int J Hyperthermia. 2019;36(1):369–375. doi:10.1080/02656736.2019.157498530829082
   PubMed Web of Science ®Google Scholar
• Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016;69(2):126–132. doi:10.4097/kjae.2016.69.2.12627066202
   PubMedGoogle Scholar
• Yoo S, Lee H-B, Han W, et al. Total intravenous anesthesia versus inhalation anesthesia for breast cancer surgery: a retrospective cohort study. Anesthesiology. 2019;130(1):31–40. doi:10.1097/ALN.000000000000249130376457
   PubMed Web of Science ®Google Scholar
• Lai H-C, Lee M-S, Lin K-T, et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in intrahepatic cholangiocarcinoma surgery. Medicine (Baltimore). 2019;98(51):e18472. doi:10.1097/MD.000000000001847231861027
   PubMed Web of Science ®Google Scholar
• Wu Z-F, Lee M-S, Wong C-S, et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery. Anesthesiology. 2018;129(5):932–941. doi:10.1097/ALN.000000000000235730028726
   PubMed Web of Science ®Google Scholar
• Jun I-J, Jo J-Y, Kim J-I, et al. Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: a retrospective observational study. Sci Rep. 2017;7(1):14020. doi:10.1038/s41598-017-14147-929070852
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang Y, Dong L, et al. Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study. Onco Targets Ther. 2018;11:1141–1148. doi:10.2147/OTT.S15679229535538
   PubMed Web of Science ®Google Scholar
• Oh TK, Kim -H-H, Jeon Y-T. Retrospective analysis of 1-year mortality after gastric cancer surgery: total intravenous anesthesia versus volatile anesthesia. Acta Anaesthesiol Scand. 2019;63(9):1169–1177. doi:10.1111/aas.1341431180151
   PubMed Web of Science ®Google Scholar
• Cata JP, Hagan KB, Bhavsar SD, et al. The use of isoflurane and desflurane as inhalational agents for glioblastoma surgery. A survival analysis. J Clin Neurosci. 2017;35:82–87. doi:10.1016/j.jocn.2016.10.00627765559
   PubMed Web of Science ®Google Scholar
• Lai H-C, Lee M-S, Lin C, et al. Propofol-based total intravenous anaesthesia is associated with better survival than desflurane anaesthesia in hepatectomy for hepatocellular carcinoma: a retrospective cohort study. Br J Anaesth. 2019;123(2):151–160. doi:10.1016/j.bja.2019.04.05731171343
   PubMed Web of Science ®Google Scholar
• Oh TK, Kim K, Jheon S, et al. Long-term oncologic outcomes for patients undergoing volatile versus intravenous anesthesia for non-small cell lung cancer surgery: a retrospective propensity matching analysis. Cancer Control. 2018;25(1):1073274818775360. doi:10.1177/107327481877536029739245
   PubMed Web of Science ®Google Scholar
• Xu Q, Shi N-J, Zhang H, Zhu Y-M. Effects of combined general-epidural anesthesia and total intravenous anesthesia on cellular immunity and prognosis in patients with non‑small cell lung cancer: A comparative study. Mol Med Rep. 2017;16(4):4445–4454. doi:10.3892/mmr.2017.714428765974
   PubMed Web of Science ®Google Scholar
• Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth. 2019;66(5):546–561. doi:10.1007/s12630-019-01330-x30834506
   PubMed Web of Science ®Google Scholar
• Hong B, Lee S, Kim Y, et al. Anesthetics and long-term survival after cancer surgery-total intravenous versus volatile anesthesia: a retrospective study. BMC Anesthesiol. 2019;19(1):233. doi:10.1186/s12871-019-0914-431852445
   PubMed Web of Science ®Google Scholar
• Jin Z, Li R, Liu J, Lin J. Long-term prognosis after cancer surgery with inhalational anesthesia and total intravenous anesthesia: a systematic review and meta-analysis. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):83–94.31333811
   PubMedGoogle Scholar
• Lim A, Braat S, Hiller J, Riedel B. Inhalational versus propofol-based total intravenous anaesthesia: practice patterns and perspectives among Australasian anaesthetists. Anaesth Intensive Care. 2018;46(5):480–487. doi:10.1177/0310057X180460050930189822
   PubMed Web of Science ®Google Scholar